Replies to post #2993 on Aurinia Pharmaceuticals Inc (AUPH)

[Lunacy_John Galt]

If there was a legitimate concern about safety with Voc...

1) The high dose group would've shown more AEs especially SAEs than the low dose and control group. Death's were in the low dose group.

2) Voc has been used in many other studies with over 2000+ patients with no safety concerns.

Between those 2 points, I'm not concerned at all with any safety issues. They have picked out the sites for the Ph. 3 trial much more carefully with what happened in Phase 2b on top of mind.